Digal, Metchelyn C.

HRN: 27-11-77  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2025
MUPIROCIN 2%, 15G (TUBE)
07/02/2025
07/09/2025
TOPICAL
15g
BID
S/P Flat Inset And Nasal Dorsal Reconstruction
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: